U.S. Markets open in 52 mins

How Pfizer's $11.4 Billion Takeover Of Array Signals More Mergers

ALLISON GATLIN
How Pfizer's $11.4 Billion Takeover Of Array Signals More Mergers

Dow Jones component Pfizer is buying biotech company Array BioPharma in an $11.4 billion deal that reaps the rewards of two approved cancer treatments. Array stock soared to a record high.